EPO Patents = 25 (Patent Applications = 7)

Average Co-Inventor Count = 5.7

ph-index = 8

Forward Citations = 193(Granted Patents)

Inventors with similar research interests:

Location History:

Frankfurt-am-Main, DE (2010)
Alzenau, DE (US) (2010)
Alzenau, DE (2002 - 2015)

Company Filing History:

22 out of 1,827

Sanofi-a Ventis Deutschland Gmbh

Aventis Pharma Deutschland, Gmbh

Years Active: 2002-2015

Loading Chart...

55 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 9079906 - Triazolopyridazines as PAR1 inhibitors, production thereof, and use as medicaments (2015-07-14),

2. 8871798 - Tricyclic pyridyl-vinyl pyrroles as PAR1 inhibitors (2014-10-28),

3. 8853206 - Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments (2014-10-07),

4. 8598177 - Imidazopyridazines as PAR1 inhibitors, production thereof, and use as medicaments (2013-12-03),

5. 8466169 - [object Object] (2013-06-18),

6. 8344004 - Cyclic pyridyl-N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals (2013-01-01),

7. 8247452 - Urea- and urethane-substituted acylureas, process for their preparation and their use (2012-08-21),

8. 8236810 - Substituted 8-aminoalkylthioxanthines, and their use as inhibitors of dipeptidyl peptidase IV (2012-08-07),

9. 8198272 - Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments (2012-06-12),

10. 8173674 - Sulfonyl-phenyl-2H-[1,2,4]oxadiazol-5-one derivatives, processes for their preparation and their use as pharmaceuticals (2012-05-08),

11. 8163774 - Amide-substituted 8-N-benzimidazoles, method for the production thereof, and use of the same as medicaments (2012-04-24),

12. 8138207 - Aminocarbonyl-substituted 8-N-benzimidazoles, methods for their preparation and their use in pharmaceutical compositions (2012-03-20),

13. 8076336 - Triazolopyridazines as PAR1 inhibitors, production thereof, and use as medicaments (2011-12-13),

14. 8003668 - Amino-substituted 8-N-benzimidazoles and methods for their use in blood sugar disorders (2011-08-23),

15. 7968546 - Pyridazinone kinase inhibitors (2011-06-28),

Title: Karl Schoenafinger - Innovative Inventor from Alzenau

Introduction: Karl Schoenafinger is a renowned inventor hailing from Alzenau, Germany, known for his groundbreaking contributions to various industries.

Latest Patents: Karl Schoenafinger holds several patents in the fields of renewable energy, sustainable technology, and advanced materials, showcasing his commitment to innovation.

Career Highlights: With a career spanning over two decades, Karl Schoenafinger has worked with leading research institutions and universities to develop cutting-edge solutions for global challenges.

Collaborations: Throughout his career, Karl Schoenafinger has collaborated with top companies, banks, and innovative startups to bring his inventions to the market, solidifying his reputation as a visionary inventor.

Conclusion: Karl Schoenafinger's passion for innovation and dedication to creating a sustainable future through his inventions make him a prominent figure in the world of inventors and innovators.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

25 patents (EPO):

Please report any incorrect information to support@idiyas.com

7 patents pending (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.